Nomogram for Astigmatism Correction of KLEx
ConditionAstigmatism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorTianjin Eye Hospital
About this trial
The goal of this clinical trial is to learn if nomogram could promote treatment outcomes in astigmatism correction. The main question it aims to answer is:
does the nomogram could promote treatment outcomes in astigmatism correction? If there is a comparison group: Researchers will compare non-nomogram adopted to see if the outcome acceptable.
Participants will ask to complete 3-month follow-up of manifest refraction and visual acuity test.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age ≥18 years; preoperative sphere -0.50 D to -10.00 D; preoperative cylinder -1.50 D to -5.00 D; stable refraction (±0.50 D) for 1 year; normal corneal topography; central corneal thickness >500 μm or predicted residual stromal bed >280 μm; intraocular pressure <21 mmHg
Disqualifiers
ocular or systematic disease
Trial design
Design model
Parallel
Treatments tested in this trial
nomogram
Procedure/Surgerynomogram was added to nomogram group
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: nomogram groupExperimental treatment 1 intervention
Group B: control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
residual astigmstism
Time frame
3 monthsSecondary outcomes
1
visual acuity
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov